Squamous Cell Carcinoma of the Anal Canal (SCAC) Clinical Trials

Find Squamous Cell Carcinoma of the Anal Canal (SCAC) Clinical Trials Near You

High Resolution Anuscopy Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The majority of anal squamous cell carcinomas (SCC) stem from infection with high-risk human papillomavirus (HPV). Anal SCC is rare among the general population but affects several populations disproportionately. High-risk groups are screened through anal swabs for anal cytology and detection of high risk human papillomavirus (HR HPV). HRA referral is recommended for individuals with abnormal cytology. HRA represents the only method to identify precancerous lesions of the anal canal, with only few specialists knowledgeable about it. At UZ Brussel, the investigators collected a wealth of data about HPV infection and its association with anal pathology. By establishing a comprehensive study, the investigators can delve into this data with specific research questions, conducting valuable research to provide answers to pressing clinical questions and contribute to advancements in medical understanding and treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• All patients who have undergone HRA and all future patients referred for HRA in UZ Brussel

• 18 years or older

• Understands and able to speak and write in French, Dutch or English

Locations
Other Locations
Belgium
UZ Brussel
RECRUITING
Jette
Contact Information
Primary
Magali Surmont
magali.surmont@uzbrussel.be
+32 2 477
Time Frame
Start Date: 2024-08-08
Estimated Completion Date: 2029-07
Participants
Target number of participants: 500
Sponsors
Leads: Universitair Ziekenhuis Brussel

This content was sourced from clinicaltrials.gov